Filters

See more specimen types...

Other countries

Results: 1 to 20 of 42

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

Early infantile epileptic encephalopathy type 7

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy Panel - Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
6969
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

EpiFirst - Neonate

Ambry Genetics
United States
1210
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

EpiFirst - IS

Ambry Genetics
United States
1717
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy: Ohtahara Syndrome NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
99
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Early Infantile Epileptic Encephalopathy NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
6664
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

SCN1A, ARX, CDKL5, SLC2A1, STXBP1, SCN2A, KCNQ2, CHRNA4, CHRNB2, CHRNA2, PCDH19, KCNQ3. NextGeneDx.Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
1212
  • C Sequence analysis of the entire coding region

Early Infantile Epileptic Encephalopathy and Benign Familial Neonatal Seizures via the KCNQ2 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Early Infantile Epileptic Encephalopathy, Dominant and X-linked NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
2624
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEKĀ® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Early Infantile Epileptic Encephalopathy Panel

Genetic Services Laboratory University of Chicago
United States
4245
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Rett, Syndrome

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
2018
  • C Sequence analysis of the entire coding region

Epileptic encephalopathies

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
3535
  • C Sequence analysis of the entire coding region

EPILEPSY HEREDITARY PANEL

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
4137
  • C Sequence analysis of the entire coding region

EpilepsyNext

Ambry Genetics
United States
104100
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epileptic encephalopathy (NGS panel for 67 genes)

CGC Genetics
Portugal
6367
  • C Sequence analysis of the entire coding region

NGS Epilepsy/Seizure Panel

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
96145
  • C Sequence analysis of the entire coding region

Single gene testing KCNQ2

CeGaT GmbH
Germany
21
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 42

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.